Dear Authors,
If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.

Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak ( for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).

Volume 14, Number 3, 2009

Intensity modulated radiotherapy (imrt) the white, black and grey: a clinical perspective

Joseph Bindhu, Sanjay Supe, Yeshwanth Pawar


The radiotherapy community has in the past few decades witnessed dramatic shift in the treatment modalities from conventional 2-D radiotherapy to the now widely practiced 3-DCRT, IMRT and evolving IGRT. IMRT has generated so much interest because of its unique dosimetric modulation to concentrate doses to the targets of interests while also being able to relatively spare neighboring normal tissue. However IMRT is not the all in one solution for radiotherapeutic management of solid malignancies.
The current enthusiasm in IMRT most be tempered with an understanding of the complexities
of IMRT planning, treatment delivery, quality assurance, monitoring and clinical limitations. The
widespread implementation of this technological innovation may have been a bit premature considering that clinical information regarding the same is still being generated. This article tries to give an overview of the potential advantages/disadvantages of IMRT in the clinical set up and the few controversies (Grey Zone) that are still being resolved. There is evidence to indicate that indiscriminately used IMRT may even harm the patient or have an inferior therapeutic index to 3DCRT. This and other pertinent issues will be covered by the authors in this short review of IMRT in clinical practice.

Signature: Rep Pract Oncol Radiother, 2009; 14(3) : 95-103


« back


Indexed in: EMBASE®, the Excerpta Medica database, the Elsevier BIOBASE (Current Awareness in Biological Sciences) and in the Index Copernicus.